Journal of AIDS and HIV Treatment

Original Research Open Access

Perceptions and Knowledge of HIV/AIDS Among Black Women: An Exploratory Study

Erica Campbell, Nizejai Anderson

Black women in the United States face disproportionate rates of HIV/AIDS, with higher new infection rates and poorer health outcomes compared to other racial and gender groups. This study seeks to explore the perceptions and knowledge surrounding HIV/AIDS among Black women, to contribute to social work and public health knowledge.

Original Research Open Access

Immunological and Virological Characteristics of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Bobo-Dioulasso Hospital, Burkina Faso

Suhaniwé Nina Pascaline Dakouo, Wilfried Wenceslas Bazié, Yacouba Sawadogo, Jacques Zoungrana, Arnaud Zougmoré, Firmin Nongodo Kaboré, Koiné Maxime Drabo, Armel Poda, Abdoul-Salam Ouédraogo

Human immunodeficiency virus infection remains a public health challenge, mostly in sub-Saharan Africa. This region accounts for 65% of those infected and contributes to 50% of new infections. The World Health Organization advocates for early antiretroviral therapy (ART) initiation for all newly diagnosed individuals. If monitoring viral load (VL) after ART initiation is increasingly common, baseline VL testing is under-utilized in resource-limited settings. 

Original Research Open Access

HIV Prevalence and Associated Risk Factors among Female Bar Waitresses in Bobo-Dioulasso, Burkina Faso

Wilfried Wenceslas Bazié, Tiandiogo Isidore Traoré, Anselme Sanon, Souleymane Tassembedo, Adjara Millogo, Ajani Ousmane Taofiki, Yvette Zoundi, Issouf Konaté

In Burkina Faso, despite the decline in HIV prevalence to below 1% in the general population since 2013, it remains high among key populations composed primarily of female sex workers (FSWs). FSWs are a heterogeneous group with various risks and practices. Within this composite group, less attention has been paid to female bar waitresses (FBWs). We conducted a cross-sectional study to investigate HIV prevalence and associated factors among FBWs in Bobo-Dioulasso. 

Commentary Open Access

The Complex Intersection of Gender-based Violence (GBV) and HIV Infection: To Understand Beyond the Obvious

Vandana Dabla

The Gender-Based Violence (GBV) and HIV/AIDS are two significant social and public health issues that intersect in a rather complex way affecting women. GBV- going beyond the physical violence, includes emotional, social and economic violence too. While GBV increases the risk of contracting HIV, being suffering from HIV infection heighten the risk of experiencing GBV. 

Review Article Open Access

Bending the Curve Through Innovations to Overcome Persistent Obstacles in HIV Prevention and Treatment

Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, Mahmood Hasen Shuhata Alubiady, Yuliang Wang

Background: HIV/AIDS remains a major global public health challenge despite significant progress in treatment. New infections and HIV-related deaths persist, fueled by disparities in prevention and care access. Purpose: This review synthesizes recent advances across key domains - from vaccine development to novel treatments to omics approaches – that collectively hold promise for ending the HIV/AIDS pandemic.

Research Article Open Access

Magnitude of HIV Index Case Testing among HIV Positive Clients Attending ART Clinic in University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2023

Lakew Asmare, Zeamnuel Anteneh Yigzaw, Tihtna Alemu

Background: Index case testing is the provision of HIV testing services to family members or sexual partners of individuals already diagnosed with HIV. Its promotion stems from its potential to detect new cases, improve testing coverage, enhance ART retention, and provide convenience to affected families. Although evidence on index case testing in Ethiopia, particularly in the study area, is lacking, even, it is regarded as a crucial strategy for reducing HIV transmission among those unaware of their HIV status.

Original Research Open Access

HIV/AIDS Care and Support Services Satisfaction for Orphan and Vulnerable Children in Northwest Ethiopia: Mixed Method Study

Lakew Asmare, Zeamnuel Anteneh Yigzaw, Tihtna Alemu

Background: The provision of comprehensive care and support services to orphans and disadvantaged children that are individualized and tailored through the use of child- and family-centered information is critical but little if any information is available on satisfaction with HIV/AIDS care among orphans and vulnerable children in Gondar. Therefore, this study aimed to assess the satisfaction of HIV/AIDS care and support service delivered to caregivers of Orphans and Vulnerable Children, Gondar City, 2023.

Review Article Open Access

Potential Advantages of a Well-balanced Nutrition Regimen for People Living with Human Immunodeficiency Virus Type -1

Daniele Basta, Olga S. Latinovic, Yutaka Tagaya, Giovannino Silvestri

This review underscores the important role of nutrition in enhancing the management of Human Immunodeficiency Virus type 1 (HIV-1). Highlighting the efficacy of dietary interventions, including, the importance of omega-3 fatty acids, vitamins D and B-12, and the Mediterranean diet, we delineate how these beneficial nutritional strategies can improve the effectiveness of combined antiretroviral therapy (cART), mitigate its side effects, and ameliorate metabolic disorders in people living with HIV-1 (PLWH). 

Review Article Open Access

Beyond the Numbers: Weight Gain Risk Factors, Implications, and Interventions among Individuals with HIV

Yesha S. Patel, Carlos D. Malvestutto

Advancements in antiretroviral therapy (ART) have significantly improved life expectancy, leading to an increased prevalence of older adults with HIV. This population may face challenges related to age-related comorbidities in addition to HIV and possibly antiretroviral therapy-related comorbidities. Among those, weight gain has emerged as an increasingly recognized problem raising clinical concern.

Research Article Open Access

Painful to Discuss: The Intersection of Chronic Pain, Mental Health, and Analgesic Use among People with HIV

Sara D. Pullen, Maria Anjanette Nuñez, Sydney Bennett, Wellsley Brown, Catherine Cronin, Maya Fleischer, Abigail Malcolm, Vijay Ramesh, Kayla Spencer

This retrospective chart review study aims to identify patients in an HIV clinical setting in an area of high HIV prevalence in Atlanta, Georgia, USA who have chronic pain, analgesic prescriptions, and/or mental health diagnoses.

Brief Report Open Access

STI Characterization in Two U.S. Veterans Health Administration Healthcare Facilities During the Early COVID-19 Pandemic

Omar Harfouch, Emily Comstock, Katherine Sittig, Rohit Talwani, Roman Kaplan, Debra Benator, Heather Rivasplata, Eleanor Wilson

This retrospective chart review of Veterans at the Maryland and Washington, D.C. VA Medical Centers showed that STI positivity ratios increased in 2020 (2018-2020). The disparity in STI risk between Black and White Veterans widened in 2020, highlighting the need for targeted evidence-based STI prevention following the COVID-19 pandemic.

Research Article Open Access

A Longitudinal Assessment of Interruptions in HIV Clinic Visits and Virologic Failure among Pregnant and Postpartum Women in the Kabeho Study

Eric W. Nawar, Katherine M Andrinopoulos, Rhoderick N Machekano, Thomas W Carton, Emily A Bobrow, Placidie Mugwaneza, Dieudonne Ndatimana

Antiretroviral therapy (ART) for women with HIV is recommended for life, yet most studies measure retention in HIV care and treatment as a binary outcome rather than patterns of intermittent clinic attendance. Pregnancy and the post-partum period are critical times to study interruptions in care, as retention among these women is particularly challenging and can affect the outcomes of both the mother and her child.

Research Article Open Access

Death and Transferred Out as Competing Event for Lost to Follow-up among HIV-positive Adults on ART, in Eastern Ethiopia Governmental Hospitals from January 2015 to December 2021; (Multicenter Competing Risk Regression Analysis)

Girum Shibeshi Argaw, Kassahun Alemu Gelaye, Ayenew Molla Lakew, Yazachew Moges Chekol, Fantu Mamo Aragaw

Lost to follow-up (LTFU) among patients on antiretroviral therapy accounts for the most of all attrition. In Sub-Saharan Africa,there is a concern regarding high rates of LTFU and early mortality in antiretroviral therapy programs. Mortality and transferred out are the potential competing events for LTFU. Ignoring these events may give an invalid estimate by overestimating the probability of the occurrence of LTFU.

Research Article Open Access

Detection of Undiagnosed Elevated Cardiovascular Risk Biomarkers among HIV-Positive Patients on Antiretroviral Therapy (ART) in Kigali-City, Rwanda

Marcus Bushaku, Caleb Nyamwange, Arthur Kwena, Marc Twagirumukiza, Jean Nepo Utumatwishima, Regine Mugeni, Victor Davila-Roman, Aurore Nishimwe, Kenneth Schectman, W Todd Cade, Dominic Reeds, Eugene Mutimura

Similar to other African countries, life expectancy of people living with HIV infection has improved due to access to antiretroviral therapy (ART) in Rwanda. However, both HIV infection and use of ART are associated with cardiovascular disease (CVD) risks, due to adverse changes in some biomarkers, causing dyslipidemia and other metabolic imbalances. Biomarkers for CVD risk in HIV-infected individuals taking ART, has not been well characterized in Rwanda.

Review Article Open Access

Mental Health and Cognitive Care for Successful Aging with HIV

Paroma Mitra

Globally, an estimated 4.2 million people above the age of 50 now have diagnosis of HIV (Human Immunodeficiency Virus) infection. Patients with HIV can now survive well into old age. Aging with HIV has been associated with medical illness however neuropsychiatric symptoms including cognitive decline and behavioral dysregulation has been directly associated with aging and having HIV.

Research Article Open Access

Plasma Levels of Secretory Calreticulin among HIV Infected Patients in Bauchi State

Ahmed Musab, Ibrahim Yazid Gobir, LAWAL ROGO, Auwal Idris Kabuga, Yahaya Zakari

Human immunodeficiency virus (HIV) is a lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome. The objective was to evaluate plasma levels of Calreticulin (CALR) in HIV positive and negative individuals.

Research Article Open Access

Patient Satisfaction and Perceptions Regarding Anti-Retroviral Therapy (ART) Services in Rural Southwestern Uganda

Amunyongire R, Nuwagaba E, Atuhaire J, Nduhuura E, Ndebiika A, Turyasingura O, Ntaro M, Rukundo GZ, Grace Nambozi

Patient satisfaction and perception of the healthcare services received contribute to compliance with treatment guidelines, retention in care, and adherence to recommendations. This is especially so in the treatment of chronic medical conditions such as HIV/AIDS. The success of antiretroviral therapy (ART) plays a fundamental role in determining the quality of life of people living with HIV/AIDS (PLWHAs).

Research Article Open Access

Tenofovir Alafenamide, Emtricitabine, and Bictegravir in Switch Strategy for HIV-1 Adult Patients Due to Previous Renal Impairment Induced by Tenofovir Disoproxil Fumarate

R Correia de Abreu, C Batista, S Caetano, Isabel Neves

 Non-AIDS comorbidities, metabolic, renal and bone toxicities associated to combined antiretroviral therapy (cART), namely NRTIs, led to dual therapy (NUC sparing regimens). Tenofovir Alafenamide Fumarate (TAF) demonstrated improved renal and bone safety profile over TDF even with mild to moderate renal impairment.

Mini Review Open Access

Known and New Routes to Neutralize HIV-1 with Camelid Single Chain Antibody Fragments

C. Theo Verrips, Gerben ten Hag, Ursula Dietrich, Harold Marcotte

In spite of all efforts to reduce transmission of HIV-1, 1.7 million persons were infected in 2019 worldwide. Whereas in the developed countries the COVID-19 pandemic is reasonably controlled within 2 years because of the fast and successful development of vaccines, nearly 40 years after the first reported cases of AIDS due to HIV-1 and in spite of tremendous efforts to develop vaccines against HIV-1, there are still no vaccines against the virus.

Research Article Open Access

Pregnancy Outcomes in Pregnant Women with HIV on Tenofovir Disoproxil Fumarate (TDF) Compared to Tenofovir Alafenamide (TAF)

Matthew A. Thimm, Alison Livingston, Rosemary Ramroop, Ahizechukwu C. Eke

HIV infection in pregnancy continues to be of significant clinical and public health importance [1,2]. The current statistics published by the World Health Organization (WHO) demonstrate that 38 million people are living with HIV in 2019, and 1.1 million (85%) pregnant women living with HIV received antiretroviral therapy (ARVs) during pregnancy and postpartum.

Short Communication Open Access

Incidence of Nephrotoxicity among People Living with Human Immunodeficiency Virus on Tenofovir Treatment in a Tertiary Hospital in the Philippines

Marja Bernardo-Buensalido, Cybele Lara R. Abad

Tenofovir disoproxil fumarate (TDF) is one of the main antiretroviral drugs of people living with human immunodeficiency virus (PLWHIV). Despite its efficacy and tolerability, there is conflicting evidence regarding TDF-associated nephrotoxicity, which is proposed to cause injury by accumulation of tenofovir (TFV) within proximal tubular cells leading to mitochondrial injury and tissue hypoxia. 

Review Article Open Access

Plant-Based Vaccines Against Infectious Human Viral Diseases: Spotlight on HIV Vaccines

Srividhya Venkataraman

Production of high value recombinant pharmaceuticals using plant-based systems, otherwise called molecular pharming has greatly advanced over the past few years.

Short Communication Open Access

Apigenin as Anti-TNF Alpha Agent

Tania Mulherkar, Rashida Ginwala, Zafar K. Khan, Pooja Jai n

Inflammatory responses, although effective in eliminating pathogens, are also associated with many diseases including asthma, chronic inflammatory diseases, atherosclerosis, cancer, diabetes, and autoimmune and degenerative diseases.

Commentary Open Access

Brain Organoids: An Emerging Model System to Study HIV-1 Neuropathogenesis

Roberta S. dos Reis, Velpandi Ayyavoo

Chronic Human Immunodeficiency Virus (HIV-1) infection in the brain results in mild cognitive, motor and sensory deficits in more than 50% of people living with HIV-1 (PLWH), despite systemic viral suppression.

Short Communication Open Access

High Levels of Pre-Treatment HIV Drug Resistance in Zimbabwe: Is this a Threat to HIV/AIDS Control?

Vinie Kouamou, Alan M McGregor

Zimbabwe is one of the countries in Southern Africa most affected by the Human Immunodeficiency Virus (HIV) epidemic. The country has the third highest HIV prevalence (12.5% among 15-49 years) in the region, with an estimated 1.4 million people living with HIV (PLHIV) to date.

Commentary Open Access

Toward Personalized Medicine for HIV/AIDS

Carla M. Kumbale, Eberhard O. Voit

In 2019, approximately 38 million people were infected with HIV worldwide [1]. Although there is still no cure that successfully eradicates the disease, combination antiretroviral therapy (cART) has improved to a point where undetectable viral loads have become achievable and HIV carriers often live almost normal lives with very substantially increased average life expectancies compared to historical data.

Commentary Open Access

Fostemsavir in Heavily Treatment-Experienced Individuals Living with HIV-1: Insights from the Phase 3 BRIGHTE Study

Max Lataillade, Peter Ackerman, Till Schoofs, Andrew Clark, Michael Kozal

Fostemsavir (Rukobia^™, ViiV Healthcare, Research Triangle Park, NC), a prodrug of the first-in-class attachment inhibitor temsavir, was developed to provide a much-needed new therapeutic option for heavily treatment-experienced (HTE) people living with HIV-1 (PLWH) who are unable to form a suppressive regimen from remaining viable antiretroviral (ARV) agents because of multidrug resistance, contraindications, prior intolerance, or other safety considerations.

Mini Review Open Access

Pre-Exposure Prophylaxis (PrEP) Safety and Tolerability in Individuals ≥ 45 Years Old

Emily Comstock, Camilia James, Robert Hegarty, Yolanda Flores, Anthony Amoroso, Rohit Talwani, Eleanor Wilson

Pre-exposure prophylaxis (PrEP) is a combination of antiretroviral medications, most commonly prescribed as two co-formulated antiretrovirals, taken as a single tablet daily to significantly reduce the risk of human immunodeficiency virus (HIV) infection in individuals at high risk.

Commentary Open Access

Commentary – HIV-Induced Extracranial Carotid Ectasia and Stroke

Rakhee Lalla, Prashant Raghavan, John W. Cole

HIV is a known risk factor for both ischemic and hemorrhagic stroke. Even with the widespread use of antiretroviral therapy, stroke incidence is higher in patients with HIV compared to non-HIV control subjects.

Commentary Open Access

Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Francesca Macaluso, Deborah R. Gustafson

Among women living with HIV (WLWH), increases in body weight and body mass index (BMI, kg/m2) have been observed after switching to the antiretroviral therapies (ART) - Integrase Inhibitors (INSTI) and/or Tenofovir Alafenamide (TAF).

Commentary Open Access

Dihydropteroate Synthase (DHPS) Gene Mutations in Human Pneumocystosis

Bijay Ranjan Mirdha

Extraordinary journey began on June 18, 1981, the Centre for Disease Control and Prevention (CDC) in United States reported a cluster of Pneumocystis carinii pneumonia (now known as Pneumocystis jirovecii (P. jirovecii) pneumonia or Pneumocystis pneumonia in five gay men in Los Angeles.

Short Communication Open Access

HIV RNA Load and Antiretroviral Drug Resistance of HIV-1 Strains in Chad on Dried Blood Spots: A Pilot Study

Nadia Djimera, Abdelaye Keita, Thomas Bourlet, Laurent Andreoletti

In low-income Sub-Saharan Africa countries, peripheral blood HIV RNA levels monitoring twice a year in antiretroviral (ARV) drugs treated patient is a major WHO recommendation since 2013.

Letter to the Editor Open Access

Remembering David Katzenstein (1952-2021)

Alan M McGregor

I first met David shortly after arriving to work in Zimbabwe in 2015. He became a colleague and friend and we continued to collaborate, after my return to the UK in 2019, and indeed until his death in Harare, Zimbabwe, from the consequences of Covid-19 infection, on January 24th, 2021, with several manuscripts of this very productive collaboration, currently still in press.

Case Series Open Access

From Silos to Solidarity: Case Study of a Patient-Centered, Integrative Approach to Opioid Tapering and Chronic Pain Mitigation in a Multidisciplinary AIDS Clinic

Sara D. Pullen, Marconi VC, del Rio C, Head C, Nimmo M, O’Neil J, Ziebart M

Chronic pain, defined as pain lasting longer than three months, is a significant public health burden and has been associated with depression, anxiety, poor quality of life and opioid use disorder (OUD).

Commentary Open Access

Pre-exposure Prophylaxis (PrEP) for HIV Infection and New Sexually Transmitted Infections: A Win-Win Opportunity?

François Aubin, Clélia Vanhaecke, Christine Drobacheff, Fabien Pelletier, Manuelle Viguier

Pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition in patients exposed to a high risk of infection such as men who have sex with men (MSM), heterosexual couples, and people who inject drugs.

Mini Review Open Access

Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations

Jelani K. Grant, Louis Vincent, Bertrand Ebner, Barry E. Hurwitz, Maria L. Alcaide, Claudia Martinez

At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China.

Case Report Open Access

Anaphylaxis Drug Reaction after Initiation of Bictegravir

Blake Max, LaToyia Roman, Jonathan Martin, Patricia DeMarais

A 44-year old Ethiopian female with a history of HIV and latent tuberculosis treated with three months of rifampin presented to the Ruth M Rothstein CORE Center complaining of pruritic rash that started the previous night.

Research Article Open Access

AIDS Related Histoplasmosis, Treatment and Prophylaxis: the Mycology Unit of FJ Muniz Hospital Experience

Fernando A Messina, Ricardo Negroni, María de las Mercedes Romero, María Gabriela Santiso

Classic histoplasmosis is a systemic endemic mycosis due to the dimorphic fungus Histoplasma capsulatum var. capsulatum. This microorganism lives as mold in rich nitrogen soil in temperate and humid regions.

Research Article Open Access

Trend of HIV Infection in a Specialized Medical Unit, 2007- 2016

Diana Iveth Rojas Terrazas, Jorge Duque Rodríguez, María Cecilia Ishida Gutíerrez, Estefani Calderón Avilés, Krissel García Hernández

The human immunodeficiency virus (HIV) has caused one of the pandemics that has most affected the world population [1], and continues to be a serious problem, since to date it has not been possible to eradicate or prevent totally new cases.

Research Article Open Access

Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV

Hugh Klein, Thomas Alex Washington

Men who have sex with other men (MSM) comprise the single largest group of individuals contracting HIV in the United States, accounting for more than one-half of all new HIV diagnoses.

Research Article Open Access

Unveiling an Atypical Response to HIV-1 Infection by the Patient Carrier of the Beta-S Globin Gene and Duffy Antigen Gene Double Mutation

Philomène Lungu Anzwal, Michel Balaka Ekwalanga, Athy Kalumba Kambote, Jeanne Kasali, Hippolyte Situakibanza, Jean-Paul Gonzalez

It is known and well documented that genetic selective pressures occur from Plasmodium falciparum, P. vivax or P. knowlesi infection of red blood cells, such led to the selection of their cell membrane antigens, hemoglobin and enzymes thus associated to several mutation including, among others.

Research Article Open Access

Metabolic Syndrome in HIV Infected Children Receiving Free HAART at a Centre of Excellence in HIV Care in Northern India

K. Rajeshwari, Chandrika Verma, Ranjan Neha, B. C. Koner, S. Anuradha

Implementation of Highly Active Antiretroviral Therapy (HAART) for patients with HIV has led to the dramatic reduction in AIDS related mortality in both children and adults [1]. With their longer life expectancy and improved quality of life, effects of ageing and other environmental factors are predisposing them to non-AIDS related morbidities, with cardiovascular diseases emerging as an important threat.

Review Article Open Access

Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence

Matthew Weichseldorfer, Alonso Heredia, Marvin Reitz, Joseph L. Bryant,

Different humanized mouse models have been introduced to enable HIV-1 research in vivo, which has been made possible by the development of immunodeficient mouse strains.

Review Article Open Access

Black Women's Contribution to the HIV/AIDS Fight

Raphael M. Mutepa, Samson Chama

After thousands of years of gender conflicts, the world now stands at the beginning of the feminine era, when women will rise to their proper standing, and the entire world will experience the harmony between men and women.

Research Article Open Access

Patient-Reported Health Outcomes among HIV-Infected Patients on Antiretroviral Therapy in a Tertiary Hospital in Dar Es Salaam, Tanzania: A Cross Sectional Study

Elisha Fred Osati, Grace Ambrose Shayo, Raphael Zozimus Sangeda, Joan Rugemalila

The use of antiretroviral therapy (ART) has resulted into HIV-infected patients living longer than it was the case in the pre-ART era [1]. Surviving patients are concerned not only with the treatment ability to extend their lives but also that their quality of life is improved on the course.

Research Article Open Access

Development of an Ultrasensitive HIV-1 DNA Detection Assay Based on an Automated πCode End-Point PCR System

Kazuo Suzuki, Jui-Yu Hu, Takaomi Ishida, Yuhung Lin, Satoshi Minote, Zhixin Liu, Julie Yeung, Leon Patrick McNally, Mitchell Starr, Angelique Levert, Philip Cunningham, John Zaunders, Chin-Shiou Huang

Currently, around 60-75% of the HIV positive patients in developed countries on anti-retroviral therapy (ART) have undetectable plasma viral load using current diagnostic PCR assays.

Research Article Open Access

Rate and Predictors of Treatment Failure among Pediatric Population Taking Highly Active Antiretroviral Therapy in Ethiopia

Yimam Getaneh, Ajanaw Yizengaw, Agajie Likie, Mulusew Getahun, Altaye Feleke, Eleni Kidane, Achmyeleh Mulugeta, Amelework Yilma, Tezera Moshago, Yibeltal Assefa, Yiming Shao

The global scaling up of treatment and care for people living with Human Immunodeficiency Virus (PLHIV) has led to a 43% decline in new HIV pediatric infections since 2003, with 330,000 newly infected children in 2011.

Research Article Open Access

HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia

Atsbeha G Egziabhier, Kidist Zealiyas, Rahel Tilahun, Mulu Girma, Gebremedihin G/Michael, Tekalign Deressa, Ebba Abate, Desta Kassa, Yibeltal Assefa

For more than 35 years, the world has grappled with an AIDS epidemic that has claimed an estimated 35.0 million [28.9 million-41.5 million] lives and at its peak threatened global stability and security.

Research Article Open Access

Health Workers’ Perspectives on the Outcomes, Enablers, and Barriers to the Implementation of HIV “Test and Treat” Guidelines in Abuja, Nigeria

Solomon Odafe, Kristen A. Stafford, Aliyu Gambo, Dennis Onotu, Mahesh Swaminathan, Ibrahim Dalhatu, Uzoma Ene, Oladipo Ademola, Ahmed Mukhtar, Ibrahim Ramat, Ehoche Akipu, Henry Debem, Andrew T. Boyd, Aboje Sunday, Bola Gobir, Man E. Charurat

HIV/AIDS continues to be a major public health disease accounting for 35 million deaths across the world. In 2016 alone, there were 1.8 million new HIV infections and 1 million deaths worldwide.

Research Article Open Access

Assessment of Attitudes toward HIV and AIDS among Undergraduate Students at a Historically Black University

Prince Andrew, Azad R. Bhuiyan, Anthony Mawson, Mohammad Shahbazi

HIV is no longer only a public health challenge, but also a global threat with a devastating negative impact that has claimed over 35 million lives globally. In 2017, about 36.9 million people live with HIV, and 1.8 million people becoming newly infected with the disease globally [1].

Research Article Open Access

Anti-HIV-1 Activity of Crocodylus mindorensis (Philippine Crocodile) Serum in Cell-free and Cell-associated Virus Interactions to Human Peripheral Blood Mononuclear Cells

Hinay, Alfredo Jr A, Cadotdot, Nelyn Mae T, Tablizo, Marilou V

Highly-Active Antiretroviral Therapy (HAART) is the recommended treatment and management strategy for HIV infection. Although the existing antiretroviral drugs are indispensably significant in improving the quality and extending the lives of HIV/ AIDS individuals, the drugs still have many limitations including development of resistance, production of toxicity, and their limited availability. 

Case Report Open Access

Primary Lymph Node Kaposi's Sarcoma in Two HIV Positive Patients Presenting with Generalized Lymphadenopathy and Pancytopenia in a Third Level Hospital in Guatemala

Pablo Pérez Pinetta, Johanna Meléndez

We present two unique cases in which two HIV positive patients with generalized lymphadenopathy and pancytopenia without any skin lesions were diagnosed with primary lymph node Kaposi´s Sarcoma after excisional biopsy of an inguinal lymph node. 

Editorial Open Access

Recent Progress in Preclinical HIV-1 Vaccine Research

Zizhang Sheng, Lawrence Shapiro

Since isolation in humans in 1983 [1,2], HIV-1 has developed into a global pandemic. But an effective HIV-1 vaccine has not been succeeded despite multiple human vaccine trials performed [3,4]. Challenges to an effective vaccine arise from intrinsic virological and immunological features of HIV-1 [3-8].

Editorial Open Access

The Impact of Marginalization on the Continuum of Care Treatment Model on African American Communities in the Southern United States

Jill Rowe

Recently, I was asked to speak at the National Academy of Public Administration (NAPA) Conference about my experiences serving as an ethnographic consultant on the National HIV Behavioral Surveillance System (NHBS¹ ) Study. 

Mini Review Open Access

CCR5 Inhibitors and HIV-1 Infection

Olga S. Latinovic, Marvin Reitz, Alonso Heredia

Cellular components are attractive targets for antiviral therapy because they do not mutate as readily as do viral proteins do [1-3]. The identification of CCR₅ as an HIV-1 coreceptor [4-7], facilitated by the discovery of the antiviral activities of CCR₅ ligand ?-chemokines [8], resulted in the development of new viral entry inhibitors to block CCR₅ binding, including both- small molecules and CCR₅ antibodies